SeaCrest Wealth Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

SeaCrest Wealth Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-15	Closed	–	–	2361
2017 Q4	$0	Buy	+15	New	+$185	﹤0.01%	2280

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

SeaCrest Wealth Management's SCMP Position: Q1 2018 in Review

SeaCrest Wealth Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 15 shares.

SeaCrest Wealth Management first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

SeaCrest Wealth Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
SeaCrest Wealth Management sold 15 Sucampo Pharmaceuticals, Inc. shares in Q1 2018.
SeaCrest Wealth Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
SeaCrest Wealth Management's Sucampo Pharmaceuticals, Inc. position peaked at $0 in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on SeaCrest Wealth Management's 13F filing for Q1 2018, filed 20 Apr 2018.